Author

E Lee

Observed name: Elizabeth K. Lee

Institution: Dana-Farber Cancer Institute

Observed institutions: Samsung Medical Center, Gachon University Gil Medical Center, Dana-Farber Cancer Institute, Sungkyunkwan University

OpenAlex ID: A5070728644

Abstract CT035: CTEP #10355 A phase 1 trial of DS-8201a and olaparib in HER2-expressing malignancies: Results from dose escalation

2026 · Elizabeth K. Lee, Andrea Wahner Hendrickson, et al. · Cancer Research

Abstract P3-08-12: PIK3CA mutations in breast cancer: Mutational landscape and clinical implications in ER+/HER2- subtype

2019 · HK Ahn, S Park, et al. · Cancer Research

Works count: 2

Citation count:

H-index:

I10-index: